开云网页登录_开云app官网入口下载苹果版

Abstract

CLC Number:

R758.63

References33

[1]	Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis[J]. J Eur Acad Dermatol Venereol, 2017, 31(2):205-212. doi:10.1111/jdv.13854pmid:27573025
[2]	Parisi R, Iskandar IYK, Kontopantelis E, et al. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study[J]. BMJ, 2020, 369:m1590.
[3]	Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris[J]. J Am Acad Dermatol, 1985, 13(3):450-456. pmid:4056119
[4]	Pezzolo E, Cazzaniga S, Colombo P, et al. Psoriasis incidence and lifetime prevalence: suggestion for a higher mortality rate in older age-classes among psoriatic patients compared to the general population in Italy[J]. Acta Derm Venereol, 2019, 99(4):400-403. doi:10.2340/00015555-3130 URL
[5]	全国银屑病流行调查组, 邵长庚, 张国威, 等. 全国1984年银屑病流行调查报告[J]. 皮肤病与性病, 1989, 11(1):60-72.
[6]	Ding X, Wang T, Shen Y, et al. Prevalence of psoriasis in China: a population-based study in six cities[J]. Eur J Dermatol, 2012, 22(5):663-667. doi:10.1684/ejd.2012.1802 URL
[7]	陈映玲. 湖北省银屑病流行病学调查报告[J]. 皮肤病与性病, 1990, 12(4):51-56.
[8]	杜升东. 辽宁省银屑病流行病学调查报告[J]. 皮肤病与性病, 1993, 15(1):72-76.
[9]	李梅娇, 王鹏, 蔡敏, 等. 海南省银屑病患病情况及危险因素流行病学调查[J]. 中华皮肤科杂志, 2013, 46(3):157-159.
[10]	刘承煌, 毛维翰, 李君蒂, 等. 上海市1985年银屑病流行病学调查报告[J]. 皮肤病与性病, 1990, 12(2):56-65.
[11]	裴广德, 杜金锋, 黄英, 等. 河南省焦作地区银屑病流行病学调查[J]. 临床皮肤科杂志, 2011, 40(3):150-151.
[12]	包寅德, 曹元华, 陈素玲, 等. 江苏省泰州市及周围县八个乡的银屑病流行情况的调查报告[J]. 皮肤病与性病, 1990, 12(2):48-55.
[13]	广州市皮肤病防治所. 广州市银屑病流行病学调查总结[J]. 皮肤病与性病, 1993, 15(2):71-77.
[14]	Chen K, Wang G, Jin H, et al. Clinic characteristics of psoriasis in China: a nationwide survey in over 12000 patients[J]. Oncotarget, 2017, 8(28):46381-46389. doi:10.18632/oncotarget.18453pmid:28637026
[15]	张学军, 陈珊宇, 王福喜, 等. 寻常型银屑病遗传流行病学分析[J]. 中华皮肤科杂志, 2000, 33(6):383.
[16]	Kamiya K, Kishimoto M, Sugai J, et al. Risk factors for the development of psoriasis[J]. Int J Mol Sci, 2019, 20(18):4347. doi:10.3390/ijms20184347 URL
[17]	Jullien D, Paul C, Shourick J, et al. Psoriasis: frequency and reasons for absenteeism results from a study on 1,609 active patients[J/OL]. J Eur Acad Dermatol Vene-reol, 2020-12-02[2021-02-22]. https://pubmed.ncbi.nlm.nih.gov/33289175/.
[18]	Szczerkowska-Dobosz A, Krasowska D, Bartosińska J, et al. Pathogenesis of psoriasis in the "omic" era. Part Ⅳ. Epidemiology, genetics, immunopathogenesis, clinical manifestation and treatment of psoriatic arthritis[J]. Postepy Dermatol Alergol, 2020, 37(5):625-634.
[19]	Mease PJ, Gladman DD, Papp KA, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics[J]. J Am Acad Dermatol, 2013, 69(5):729-735. doi:10.1016/j.jaad.2013.07.023 URL
[20]	Ogdie A, Weiss P. The epidemiology of psoriatic arthritis[J]. Rheum Dis Clin North Am, 2015, 41(4):545-568. doi:10.1016/j.rdc.2015.07.001 URL
[21]	戴生明, 毕新岭. 银屑病关节炎[M]. 人民卫生出版社, 2017.
[22]	Woo YR, Park CJ, Kang H, et al. The risk of systemic diseases in those with psoriasis and psoriatic arthritis: from mechanisms to clinic[J]. Int J Mol Sci, 2020, 21(19):7041. doi:10.3390/ijms21197041 URL
[23]	Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: epidemiology[J]. J Am Acad Dermatol, 2017, 76(3):377-390. doi:S0190-9622(16)30626-0pmid:28212759
[24]	Ahlehoff O, Gislason GH, Charlot M, et al. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study[J]. J Intern Med, 2011, 270(2):147-157. doi:10.1111/j.1365-2796.2010.02310.xpmid:21114692
[25]	Gui XY, Yu XL, Jin HZ, et al. Prevalence of metabolic syndrome in Chinese psoriasis patients: a hospital-based cross-sectional study[J]. J Diabetes Investig, 2018, 9(1):39-43. doi:10.1111/jdi.12663 URL
[26]	Vaengebjerg S, Skov L, Egeberg A, et al. Prevalence, incidence, and risk of cancer in patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis[J]. JAMA Dermatol, 2020, 156(4):421-429. doi:10.1001/jamadermatol.2020.0024pmid:32074260
[27]	Wu JJ, Nguyen TU, Poon KY, et al. The association of psoriasis with autoimmune diseases[J]. J Am Acad Dermatol, 2012, 67(5):924-930. doi:10.1016/j.jaad.2012.04.039 URL
[28]	Tian Z, Huang Y, Yue T, et al. A Chinese cross-sectional study on depression and anxiety symptoms in patients with psoriasis vulgaris[J]. Psychol Health Med, 2019, 24(3):269-280. doi:10.1080/13548506.2018.1529323 URL
[29]	李蔚然. 基于银屑病全球监测项目的中国银屑病医疗保健现状研究及银屑病与肥胖、Ⅱ型糖尿病的因果关系探讨[D]. 安徽: 安徽医科大学, 2020.
[30]	Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review[J]. JAMA, 2020, 323(19):1945-1960. doi:10.1001/jama.2020.4006pmid:32427307
[31]	Kaushik SB, Lebwohl MG. Psoriasis: Which therapy for which patient: psoriasis comorbidities and preferred systemic agents[J]. J Am Acad Dermatol, 2019, 80(1):27-40. doi:10.1016/j.jaad.2018.06.057 URL
[32]	Strober B, Gooderham M, de Jong EMGJ, et al. Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry(PSOLAR)[J]. J Am Acad Dermatol, 2018, 78(1):70-80. doi:S0190-9622(17)32316-2pmid:29102053
[33]	陈小兰, 郑丽英, 张昊, 等. 银屑病患者疾病负担和生存质量调查:基于网络的问卷调查[J]. 中华皮肤科杂志, 2019, 52(11):791-795.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References33

Related Articles3

Recommended Articles

Metrics

Comments

[1]	.[J]. Journal of Diagnostics Concepts & Practice, 2021, 20(01): 37-42.
[2]	LIN Zhen, GUO Ruru, LÜ Liangjing, CHEN Xiaoxiang.Study on the involving of Fra2viaregulating IL23 receptor in the pathogenesis of psoriasis[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(03): 254-259.
[3]	.[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(03): 238-243.